Table 2 Prospective studies showing that TyG index predicts incident T2DM
From: The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes
Park et al. | Rong et al. | Li et al. | Lopez Jaramillo et al. | Wang et al. | |
|---|---|---|---|---|---|
Year | 2022 | 2023 | 2020 | 2023 | 2021 |
Country | Korea | China | China | 22 countries | China |
Participants | N = 4285 lean adults | N = 862 elderly | N = 201,298 | N = 141,243 | N-684 |
(40–69 yrs) | > 60 yrs (67–80 yrs.) | > 20 yrs | 35–70 yrs | 44–53 yrs | |
48% Male | 47% Male | 32% Male | 41% Male | 58% | |
Follow up | 12 yrs | 20 yrs | 3.12 yrs | 13.2 yrs | 15 yrs |
Incident T2DM diagnosis | 14.7% | 63.1% | 15.6% | 5.5% | 10.8% |
TyG Index: HR Quartiles/Tertiles | 1.00, 1.63 (95%CI, 1.18–2.24), 2.30 (95%CI, 1.68–3.14), and 3.67 (95%CI, 2.71–4.98) | Tertiles 1.00, 1.457 (95%CI 1.17–1.80) and 1.70 (95%CI 1.37–2.11). | 1.00, 1.83 (1.49–2.26), 3.29 (2.70–4.01) and 6.26 (5.15–7.60) | Tertiles 1.00, 1.54 (1.01–1.67); 1.99 (1.82–2.16) | Quartile 1.00, 0.77 (0.28–2.13), 0.611 (0.65–3.66), 3.36 (1.52–7.39) |